title: High-Cost, High-Value Oral Specialty Drugs: More Evidence on the Impact of Cost Sharing in Medicare Part D.
authors.affiliation: Scott F. Huntington, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT; and Amy J. Davidoff, Yale School of Public Health and Yale Cancer Center, Yale University, New Haven, CT.
authors.forename: Scott F
authors.initials: SF
authors.lastname: Huntington
authors.affiliation: Scott F. Huntington, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT; and Amy J. Davidoff, Yale School of Public Health and Yale Cancer Center, Yale University, New Haven, CT.
authors.forename: Amy J
authors.initials: AJ
authors.lastname: Davidoff
mesh_terms: D017047:Cost Sharing; D016527:Drug Costs; D005102:Health Expenditures; D006801:Humans; D006278:Medicare; D054524:Medicare Part D; D014481:United States